ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,366Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 6969

$1.21M Total Retail Price of All Prescriptions

Rank: 101 out of 6969

772 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 772 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 772 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 21,145 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 936 727 1 1
AMLODIPINE BESYLATE 905 823 2 4
LISINOPRIL 764 596 3 2
ALENDRONATE SODIUM 733 667 4 14
METFORMIN HCL 732 583 5 7
LEVOTHYROXINE SODIUM 689 531 6 5
OMEPRAZOLE 682 482 7 6
FUROSEMIDE 530 430 8 10
HYDROCODONE-ACETAMINOPHEN 513 304 S3 9 3
ATENOLOL 513 409 9 9
TRAMADOL HCL 482 369 11 27
DICLOFENAC SODIUM 458 401 12 78
GABAPENTIN 408 335 13 17
METOPROLOL TARTRATE 365 319 14 13
GLIMEPIRIDE 364 337 15 44
TAMSULOSIN HCL 334 256 16 23
PANTOPRAZOLE SODIUM 333 270 17 31
DIOVAN 333 297 17 26
BENAZEPRIL HCL 307 235 19 18
DONEPEZIL HCL 285 265 20 32
IBUPROFEN 278 150 21 29
MEGESTROL ACETATE 277 203 R 22 129
FAMOTIDINE 264 233 23 37
CLONIDINE HCL 263 239 24 59
LOVASTATIN 250 216 25 15
AZITHROMYCIN 243 194 26 42
GLIPIZIDE 238 231 27 21
LOSARTAN POTASSIUM 227 213 28 12
ATORVASTATIN CALCIUM 221 186 29 11
ADVAIR DISKUS 217 181 30 45
ALLOPURINOL 209 150 31 35
BACLOFEN 207 125 32 86
GEMFIBROZIL 204 144 33 85
TRIAMTERENE-HCTZ 190 123 34 58
HYDROCHLOROTHIAZIDE 188 153 35 8
TRIAMCINOLONE ACETONIDE 183 163 36 55
THEOPHYLLINE ANHYDROUS 180 116 37 287
PLAVIX 174 143 38 68
POTASSIUM CHLORIDE 173 120 39 30
FENOFIBRATE 168 132 40 63
CRESTOR 167 147 41 39
WARFARIN SODIUM 167 167 41 20
AVODART 164 114 43 108
JANUVIA 162 129 44 41
PROAIR HFA 160 136 45 33
TERAZOSIN HCL 160 140 45 49
PROMETHAZINE VC 155 129 R 10 47 401
NEXIUM 145 118 48 52
CLOTRIMAZOLE-BETAMETHASONE 142 123 49 182
OXYBUTYNIN CHLORIDE 142 93 49 126
RANITIDINE HCL 140 100 51 46
ZOLPIDEM TARTRATE 134 130 52 16
CARISOPRODOL 130 0 R 53 69
METOPROLOL SUCCINATE 128 125 54 22
CLOPIDOGREL 128 111 54 48
ENALAPRIL MALEATE 126 74 56 56
GLYBURIDE 126 112 R 56 54
CARBIDOPA-LEVODOPA 124 94 58 119
GLYBURIDE-METFORMIN HCL 123 105 R 59 92
METOCLOPRAMIDE HCL 119 73 60 136
DEXILANT 117 98 61 110
DIOVAN HCT 117 85 61 57
CEPHALEXIN 117 83 61 96
PRAVASTATIN SODIUM 114 70 64 19
NAMENDA 114 102 64 51
MELOXICAM 109 107 66 36
TRICOR 106 81 67 143
TRAZODONE HCL 105 56 68 47
ACTOS 104 82 69 61
SYMBICORT 103 76 70 149
SPIRIVA 100 85 71 66
DIGOXIN 99 93 72 71
SINGULAIR 99 85 72 84
CARVEDILOL 98 83 74 25
DIVALPROEX SODIUM 96 54 75 103
DILTIAZEM 24HR ER 96 93 75 183
NAPROXEN 95 50 77 62
LANTUS 95 79 77 50
DETROL LA 95 63 77 223
NIFEDIPINE ER 88 75 80 95
CILOSTAZOL 87 62 81 208
PRANDIN 86 77 82 271
LEVETIRACETAM 84 33 83 128
ISOSORBIDE MONONITRATE ER 83 71 84 81
ACETAMINOPHEN-CODEINE 81 65 S3 85 73
KLOR-CON 8 80 67 86 104
ZETIA 79 79 87 98
INSULIN SYRINGE 78 68 88 60
ECONAZOLE NITRATE 74 50 89 290
PHENYTOIN SODIUM EXTENDED 70 30 90 169
CITALOPRAM HBR 70 56 90 34
HUMULIN 70-30 69 65 92 294
CLOBETASOL PROPIONATE 69 68 92 230
OLANZAPINE 67 54 94 139
RISPERIDONE 67 42 94 88
OXYBUTYNIN CHLORIDE ER 66 62 96 165
LEVOFLOXACIN 65 58 97 109
FLUOXETINE HCL 64 64 98 43
ACIPHEX 64 50 98 181
COLCRYS 62 60 100 211
VERAPAMIL ER 62 50 100 133
ISOSORBIDE DINITRATE 61 61 102 231
DIPYRIDAMOLE 60 59 R 103 565
PROPRANOLOL HCL 59 23 104 153
SERTRALINE HCL 59 20 104 38
CIPROFLOXACIN HCL 59 48 104 64
IBANDRONATE SODIUM 58 50 107 178
EVISTA 58 58 107 118
NATEGLINIDE 56 56 109 228
PATANOL 55 55 110 142
SPIRONOLACTONE 53 38 111 102
ROPINIROLE HCL 52 49 112 162
LIPITOR 52 47 112 89
VENTOLIN HFA 51 49 114 125
TRILIPIX 51 33 114 175
CYMBALTA 51 23 114 72
MONTELUKAST SODIUM 50 40 117 151
FINASTERIDE 50 46 117 80
CARBAMAZEPINE 50 28 117 204
AMIODARONE HCL 50 50 117 184
POLYETHYLENE GLYCOL 3350 50 47 117 127
PREDNISONE 50 35 117 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.